Upgrade to SI Premium - Free Trial

PTC Therapeutics (PTCT) Misses Q3 EPS by 30c, Revenues Miss

October 29, 2019 4:54 PM
PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($1.06), $0.30 worse than the analyst estimate of ($0.76). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Management Comments

Next Articles